Market Tracker

02/21 5:15pm ET

Johnson & Johnson (NYSE:JNJ)

129.91
Delayed Data
As of Feb 21
 -0.96 / -0.73%
Today’s Change
118.32
Today|||52-Week Range
148.32
-7.02%
Year-to-Date
JNJ Regular Dividend: JNJ will begin trading ex-dividend on 02/26/18 with a $0.84 dividend payable to shareholders of record as of 02/27/18.
What's in the Cards for Geron (GERN) This Earnings Season?
Feb 20 / Zacks.com - Paid Partner Content
AbbVie Hikes Dividend by 35%, Launches $10B Buyback Plan
Feb 16 / Zacks.com - Paid Partner Content
Captrust Financial Advisors Buys Apple Inc, Johnson & Johnson, Bank of America Corpor...
Feb 19 / GuruFocus News - Paid Partner Content
J&J (JNJ) Gets FDA Nod for New Prostate Cancer Treatment (Revised)
Feb 16 / Zacks.com - Paid Partner Content
Charlie Tian: Standing on the Shoulders of the Gurus
Feb 19 / GuruFocus News - Paid Partner Content
J&J (JNJ) Gets FDA Nod for New Prostrate Cancer Treatment
Feb 15 / Zacks.com - Paid Partner Content
Jim Cramer: Drug Stocks on the Move
Feb 16 / TheStreet.com - Paid Partner Content
Why Defensive ETFs Fail in the Market Downturn?
Feb 14 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Cisco Beats, Caterpillar January Sales up 34%
Feb 16 / Zacks.com - Paid Partner Content
FDA Okays J&J's Prostate Cancer Drug in First-Line Setting
Feb 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close130.87
Today’s open130.80
Day’s range129.86 - 132.43
Volume6,578,047
Average volume (3 months)6,821,754
Market cap$351.6B
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)-92.07%
Earnings growth (this year)+10.95%
Earnings growth (next 5 years)+7.15%
Revenue growth (last year)+6.27%
P/E ratio22.6
Price/Sales5.02
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.25-0.69%
NVSNovartis-0.48-0.56%
MRKMerck-0.43-0.78%
SNYSanofi-0.04-0.10%
Data as of 4:02pm ET, 02/21/2018

Financials

Next reporting dateApril 17, 2018
EPS forecast (this quarter)$2.01
Annual revenue (last year)$76.5B
Annual profit (last year)$1.3B
Net profit margin1.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Alex Gorsky
Chief Financial Officer &
Vice President
Dominic J. Caruso
Corporate headquarters
New Brunswick, New Jersey

Forecasts